Alaxo Airway Stents
Alaxo Airway Stents offers an innovative solution for healthy nasal breathing, snoring, and athletic performance, under the slogan "Helping the World Breathe Better!". The company, founded in 2019, specializes in stent-based therapy to support natural nasal breathing. Their product line is clinically proven to improve nasal breathing, snoring, sleep quality, and athletic performance. Notably, the AlaxoStent is clinically tested for treating obstructive sleep apnea and snoring, while also supporting quality of life issues such as allergies, rhinitis, sinusitis, and autoimmune diseases.
Alaxo Airway Stents' products are internationally patented and possess the necessary regulatory clearances including the CE Mark, FDA, and Health Canada approvals. The stents are designed for daily and nightly use, wearable for up to 18 hours a day.
Though specific details about the headquarter location and recent investment are not available, the company operates within the industries of Design, Manufacturing, Medical Devices, Logistics, and Delivery.
For further information, visit their websites: www.alaxocanada.com or www.alaxousa.com.
There is no investment information
No recent news or press coverage available for Alaxo Airway Stents.